Lably
Skip to content

Virus latency

Ability of some viruses to lie dormant within a cell

  • 6 min read
  • 3 chapters

Related on Lably

Through Pathogen, Virus and Neuron

Virus latency is not to be confused with clinical latency during the incubation period when a virus is not dormant.

Mechanisms

Episomal latency

Episomal latency refers to the use of genetic episomes—extrachromosomal DNA elements—by a virus during its latent phase. In this latency type, viral genes are stabilized and maintained separately from the host genome, floating within the cell nucleus or cytoplasm as distinct structures. Episomes can be linear or lasso-shaped structures. Compared to proviral latency, episomal latency is more vulnerable to targeted ribozymes—catalytic RNAs designed to cleave specific sequences—and to degradation by host cellular mechanisms, such as nucleases and components of the immune response. Proviral latency, in contrast, involves integration of viral DNA into the host genome, which confers greater stability and resistance to such degradation, ensuring long-term persistence of the viral genome (see below).

Herpesviridae

Members of the Herpesviridae family of viruses (a.k.a. herpesviruses) all establish latent infection. Among the herpesviruses are varicella zoster virus (VZV), which causes chickenpox and shingles, and herpes simplex viruses 1 and 2 (HSV-1 and HSV-2), all of which establish episomal latency in neurons and leave linear genetic material floating in the cytoplasm.

Epstein-Barr virus

The Gammaherpesvirinae subfamily is associated with episomal latency established in cells of the immune system, such as B-cells in the case of Epstein–Barr virus (EBV). EBV lytic reactivation (which can be due to chemotherapy, radiation, or other stressors) can result in genome instability and cancer. As of November 2025, epidemiological and immunological evidence increasingly suggests that EBV is an etiologic factor in multiple sclerosis pathogenesis, as well.

Herpes simplex virus

In the case of herpes simplex, HSVs have been shown to fuse with DNA in neurons, including those in nerve ganglia, and reactivate upon even minor chromatin loosening with stress. However, the chromatin compacts (i.e., becomes latent) upon oxygen and nutrient deprivation.

Cytomegalovirus

Cytomegalovirus (CMV) establishes latency in myeloid progenitor cells and is reactivated by inflammation. Immunosuppression and critical illness (sepsis, in particular) often results in CMV reactivation. CMV reactivation is commonly seen in patients with severe colitis.

Reactivation

Reactivation of herpesviruses can occur in response to stress stimuli that affect neurons innervated by the infected ganglion. This can happen locally when neurons are subjected to physical or emotional stress, such as trauma or psychological pressure, or systemically through mechanisms like elevated body temperature during fever or heat exposure, which disrupt viral latency and promote reactivation.

Advantages and disadvantages

Advantages of episomal latency include the possibility that the virus may not need to enter the cell nucleus, thereby avoiding nuclear domain 10 (ND10) from activating interferon via that pathway. Disadvantages include greater exposure to cellular defenses, potentially leading to degradation of the viral gene by cellular enzymes.

Proviral latency

A provirus is a viral genome that is integrated into the DNA of a host cell.

Advantages and disadvantages

Advantages include automatic host cell division, which results in replication of the virus's genes, and the fact that it is nearly impossible to remove an integrated provirus from an infected cell without killing the cell. A disadvantage of this method is the need to enter the nucleus (and the need for packaging proteins that enable it). However, viruses that integrate into the host cell's genome can stay there as long as the cell lives.

HIV

One of the best-studied viruses that exhibits viral latency is HIV. HIV uses reverse transcriptase to create a DNA copy of its RNA genome. HIV latency allows the virus to largely avoid the immune system. Like other viruses that enter dormancy, HIV does not typically cause symptoms while latent. HIV in proviral latency is nearly impossible to target with antiretroviral drugs. As of September 2021, several classes of latency-reversing agents (LRAs) are under development for possible use in shock-and-kill strategies, in which the latently infected cellular reservoirs would be reactivated (the shock) so that antiviral drug treatment could take effect (the kill).

Sign in to keep reading

2 more chapters are free with a Lably account.

More in Plants